[1] [1] GALICIA-GARCIA U, BENITO-VICENTE A, JEBARI S, et al. Pathophysiology of type 2 diabetes mellitus［J］. International Journal of Molecular Sciences, 2020, 21(17): 6275-6308.

[2] [2] WILLIAMS R, KARURANGA S, MALANDA B, et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition［J］. Diabetes Research and Clinical Practice, 2020, 162: 108072-108084.

[3] [3] INAISHI J, SAISHO Y. Beta-cell mass in obesity and type 2 diabetes, and its relation to pancreas fat: a mini-review［J］. Nutrients, 2020, 12(12): 3846-3851.

[4] [4] KORBECKI J, BAJDAK-RUSINEK K. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms［J］. Infammation Research, 2019, 68(11): 915-932.

[5] [5] SAMSONOV M V, PODKUYCHENKO N V, KHAPCHAEV A Y, et al. AICAR protects vascular endothelial cells from oxidative injury induced by the long-term palmitate excess［J］. International Journal of Molecular Sciences, 2021, 23(1): 211-226.

[6] [6] KUHRE R E, HOLST J J, KAPPE C. The regulation of function, growth and survival of GLP-1-producing L-cells［J］. Clinical Science, 2016, 130(2): 79-91.

[7] [7] CERF M E. Developmental programming and glucolipotoxicity: insights on beta cell inflammation and diabetes［J］. Metabolites, 2020, 10(11): 444-457.

[8] [8] TZENG H T, CHYUAN I T, CHEN W Y. Shaping of innate immune response by fatty acid metabolite palmitate［J］. Cells, 2019, 8(12): 1633-1647.

[9] [9] SINGH A, KUKRETI R, SASO L, et al. Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes［J］. Molecules, 2022, 27(3): 950-969.

[10] [10] MUKHERJEE N, LIN L, CONTRERAS C J, et al. Beta-cell death in diabetes: past discoveries, present understanding, and potential future advances［J］. Metabolites, 2021, 11(11): 796-824.

[11] [11] KOWLURU A. Oxidative stress in cytokine-induced dysfunction of the pancreatic beta cell: known knowns and known unknowns［J］. Metabolites, 2020, 10(12): 480-496.

[12] [12] MIKI A, RICORDI C, SAKUMA Y, et al. Divergent antioxidant capacity of human islet cell subsets: a potential cause of beta-cell vulnerability in diabetes and islet transplantation［J］. PLoS One, 2018, 13(5): e196570-e196585.

[13] [13] LENZEN S. Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic β-cells［J］. Biochimica et Biophysica Acta-General Subjects, 2017, 1861(8): 1929-1942.

[14] [14] LY L D, LY D D, NGUYEN N T, et al. Mitochondrial Ca2+ uptake relieves palmitate-induced cytosolic Ca2+ overload in MIN6 cells［J］. Molecules and Cells, 2020, 43(1): 66-75.

[15] [15] LY L D, XU S, CHOI S K, et al. Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes［J］. Experimental and Molecular Medicine, 2017, 49(2): e291-e302.

[16] [16] OH Y S, BAE G D, BAEK D J, et al. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes［J］. Frontiers in Endocrinol (Lausanne), 2018, 9: 384-393.

[17] [17] YARIBEYGI H, SATHYAPALAN T, ATKIN S L, et al. Molecular mechanisms linking oxidative stress and diabetes mellitus［J］. Oxidative Medicine and Cellular Longevity, 2020, 2020: 8609213-8609225.

[18] [18] GIRONA J, ROSALES R, SAAVEDRA P, et al. Palmitate decreases migration and proliferation and increases oxidative stress and inflammation in smooth muscle cells: role of the Nrf2 signaling pathway［J］. American Journal of Physiology-Cell Physiology, 2019, 316(6): C888-C897.

[19] [19] ZHOU J, ZHANG X, JI L, et al. Identification of potential biomarkers of type 2 diabetes mellitus-related immune infiltration using weighted gene coexpression network analysis［J］. BioMed Research International, 2022, 2022: 9920744-9920757.

[20] [20] YING W, FU W, LEE Y S, et al. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities［J］. Nature Reviews Endocrinology, 2020, 16(2): 81-90.

[21] [21] PERRY B D, RAHNERT J A, XIE Y, et al. Palmitate-induced ER stress and inhibition of protein synthesis in cultured myotubes does not require Toll-like receptor 4［J］. PLoS One, 2018, 13(1): e191313-e191328.

[22] [22] LEE J H, LEE J. Endoplasmic reticulum (ER) stress and its role in pancreatic beta-cell dysfunction and senescence in type 2 diabetes［J］. International Journal of Molecular Sciences, 2022, 23(9): 4843-4864.

[23] [23] STONE S I, ABREU D, MCGILL J B, et al. Monogenic and syndromic diabetes due to endoplasmic reticulum stress［J］. Journal of Diabetes and its Complications, 2021, 35(1): 107618-107624.

[24] [24] LEE K, CHAN J Y, LIANG C, et al. XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice［J］. Diabetologia, 2022, 65(6): 984-996.

[25] [25] LEMMER I L, WILLEMSEN N, HILAL N, et al. A guide to understanding endoplasmic reticulum stress in metabolic disorders［J］. Molecular Metabolism, 2021, 47: 101169-101187.

[26] [26] LYTRIVI M, CASTELL A L, POITOUT V, et al. Recent insights into mechanisms of beta-cell lipo- and glucolipotoxicity in type 2 diabetes［J］. Journal of Molecular Biology, 2020, 432(5): 1514-1534.

[27] [27] TIWARY S, NANDWANI A, KHAN R, et al. GRP75 mediates endoplasmic reticulum-mitochondria coupling during palmitate-induced pancreatic beta-cell apoptosis［J］. Journal of Biological Chemistry, 2021, 297(6): 101368-101383.

[28] [28] WANG Y, LIU J, LIU Z, et al. Sall2 knockdown exacerbates palmitic acid induced dysfunction and apoptosis of pancreatic NIT-1 beta cells［J］. Biomed Pharmacother, 2018, 104: 375-382.

[29] [29] HUANG J S, GUO B B, WANG G H, et al. DGAT1 inhibitors protect pancreatic beta-cells from palmitic acid-induced apoptosis［J］. Acta Pharmacologica Sinica, 2021, 42(2): 264-271.

[30] [30] YALCIN A, SARKICI G, KOLAC U K. PKR inhibitors suppress endoplasmic reticulum stress and subdue glucolipotoxicity-mediated impairment of insulin secretion in pancreatic beta cells［J］. Turkish Journal of Biology, 2020, 44(2): 93-102.

[31] [31] HONG S W, LEE J, CHO J H, et al. Pioglitazone attenuates palmitate-induced inflammation and endoplasmic reticulum stress in pancreatic beta-cells［J］. Endocrinology and Metabolism, 2018, 33(1): 105-113.

[32] [32] DEL P S, CHILTON R. Practical strategies for improving outcomes in T2DM: the potential role of pioglitazone and DPP4 inhibitors［J］. Diabetes, Obesity and Metabolism, 2018, 20(4): 786-799.

[33] [33] CREMONINI E, OTEIZA P I. (-)-Epicatechin and its metabolites prevent palmitate-induced NADPH oxidase upregulation, oxidative stress and insulin resistance in HepG2 cells［J］. Archives of Biochemistry and Biophysics, 2018, 646: 55-63.

[34] [34] PARK J, JUNG T W, CHUNG Y H, et al. 1, 2-dilinoleoyl-sn-glycero-3-phosphocholine increases insulin sensitivity in palmitate-treated myotubes and induces lipolysis in adipocytes［J］. Biochemical and Biophysical Research Communications, 2020, 533(1): 162-167.

[35] [35] WALKER A K. 1-carbon cycle metabolites methylate their way to fatty liver［J］. Trends in Endocrinology and Metabolism, 2017, 28(1): 63-72.

[36] [36] BHATT-WESSEL B, JORDAN T W, MILLER J H, et al. Role of DGAT enzymes in triacylglycerol metabolism［J］. Archives of Biochemistry and Biophysics, 2018, 655: 1-11.

[37] [37] JO S I, BAE J H, KIM S J, et al. PF-04620110, a potent antidiabetic agent, suppresses fatty acid-induced NLRP3 inflammasome activation in macrophages［J］. Diabetes & Metabolism, 2019, 43(5): 683-699.

[38] [38] HONG D J, JUNG S H, KIM J, et al. Synthesis and biological evaluation of novel thienopyrimidine derivatives as diacylglycerol acyltransferase 1 (DGAT-1) inhibitors［J］. Journal of Enzyme Inhibition and Medicinal Chemistry, 2020, 35(1): 227-234.

[39] [39] KOUL S, KURHADE S, BHOSALE S, et al. Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation［J］. Bioorganic & Medicinal Chemistry Letters, 2022, 62: 128632-128637.

[40] [40] CHEN G, YANG X, YANG X, et al. Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving beta cell function and reducing insulin resistance in diabetic rats［J］. BMC Complementary Medicine and Therapies, 2017, 17(1): 507-517.

[41] [41] FAN X M, ZHANG C, NIU S W, et al. Ginsenoside Rg1 attenuates hepatic insulin resistance induced by high-fat and high-sugar by inhibiting inflammation［J］. European Journal of Pharmacology, 2019, 854: 247-255.

[42] [42] MO J, ZHOU Y, YANG R, et al. Ginsenoside Rg1 ameliorates palmitic acid-induced insulin resistance in HepG2 cells in association with modulating Akt and JNK activity［J］. Pharmacological Reports, 2019, 71(6): 1160-1167.

[43] [43] YUAN Y L, LIN B Q, ZHANG C F, et al. Timosaponin B-II ameliorates palmitate-induced insulin resistance and inflammation via IRS-1/PI3K/Akt and IKK/NF-κB pathways［J］. The American Journal of Chinese medicine, 2016, 44(4): 755-769.

[44] [44] JI K Y, KIM K M, KIM Y H, et al. The enhancing immune response and anti-inflammatory effects of Anemarrhena asphodeloides extract in RAW 264.7 cells［J］. Phytomedicine, 2019, 59: 152789-152822.

[45] [45] HAN Y B, TIAN M, WANG X X, et al. Berberine ameliorates obesity-induced chronic inflammation through suppression of ER stress and promotion of macrophage M2 polarization at least partly via downregulating lncRNA Gomafu［J］. International Immunopharmacology, 2020, 86: 106741-106751.

[46] [46] LYU X, ZHAO Y, YANG X, et al. Berberine potentiates insulin secretion and prevents beta-cell dysfunction through the miR-204/SIRT1 signaling pathway［J］. Frontiers in Pharmacology, 2021, 12: 720866-720879.

[47] [47] CHEN X F, YI L, SONG S, et al. Puerarin attenuates palmitate-induced mitochondrial dysfunction, impaired mitophagy and inflammation in L6 myotubes［J］. Life Sciences, 2018, 206: 84-92.

[48] [48] MALIK S A, ACHARYA J D, MEHENDALE N K, et al. Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation［J］. Free Radical Research, 2019, 53(7): 815-827.

[50] [50] CUI X, QIAN D W, JIANG S, et al. Scutellariae radix and coptidis rhizoma improve glucose and lipid metabolism in T2DM rats via regulation of the metabolic profiling and MAPK/PI3K/Akt signaling pathway［J］. International Journal of Molecular Sciences, 2018, 19(11): 3634-3655.

[51] [51] SUN J P, SHI L, WANG F, et al. Modified Linggui Zhugan decoction ameliorates glycolipid metabolism and inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 alpha signaling pathways in obese type 2 diabetic rats［J］. Chinese Journal of Integrative Medicine, 2022, 28(1): 52-59.

[52] [52] LIU Q, LIU S, GAO L, et al. Anti-diabetic effects and mechanisms of action of a Chinese herbal medicine preparation JQ-R in vitro and in diabetic KK(Ay) mice［J］. Acta Pharmaceutica Sinica B, 2017, 7(4): 461-469.